Washington, Dec 25: US-based pharmaceutical company Moderna expects that its COVID-19 vaccine would be effective against the new strains of the coronavirus that have discovered in the United Kingdom.
In an official statement, Moderna said, “Based on the data to date, Moderna expects that the vaccine-induced immunity from the Moderna COVID-19 Vaccine would be protective against the variants of the SARS-CoV-2 virus recently described in the UK. We will be performing additional tests of the vaccine in the coming weeks to confirm this expectation.”
London confirmed that a new strain of coronavirus has been detected in the country, adding that the new variant is 70 per cent more transmissible than other SARS-CoV-2 variants.
After this declaration many countries suspended travel to and from the UK. However, there is no evidence that the new strain is more pathogenic.
On Wednesday, UK Health Secretary Matt Hancock said that a second new variant of the SARS-CoV-2 allegedly originating from South Africa was found in the country. On Thursday, the United Kingdom banned entry for passengers traveling from South Africa .
